Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapeutic vulnerabilities in triple negative breast cancer: Stem-like traits explored within molecular classification.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie - 1 May 2024

Huang Peng, Zhang Xi, Prabhu Jyothi S, Pandey Vijay

Abstract excerpt

Triple Negative Breast Cancer (TNBC) is the most aggressive type of breast cancer (BC). Despite advances in the clinical management of TNBC, recurrence-related mortality remains a challenge. The stem-like phenotype of TNBC plays a significant role in the persistence of minimal disease residue after therapy. Individuals exhibiting stem-like characteristics are particularly prone to inducing malignant relapse...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Cancer Cells and Metastasis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cancer Genomics and Diagnostics

Share to Lung Cancer Treatments and Mutations

Share to Neoplasm Recurrence, Local

Share to Neoplastic Stem Cells

Share to Phenotype

Share to Triple Negative Breast Neoplasms

Source

Identifiers

PMID: 38613998
DOI: 10.1016/j.biopha.2024.116584

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapeutic vulnerabilities in triple negative breast cancer: Stem-like traits explored within molecular classification.PMID 38613998Read ↗

Breast Cancer Stem Cells and Tumor Heterogeneity: Characteristics and Therapeutic StrategiesSemantic proximity Read ↗

Update on triple‐negative breast cancers – highlighting subtyping update and treatment implicationSemantic proximity Read ↗

Divide and Conquer—Targeted Therapy for Triple-Negative Breast CancerSemantic proximity Read ↗

Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment optionsSemantic proximity Read ↗

Breast Cancer Stem Cells: Biomarkers, Identification and Isolation Methods, Regulating Mechanisms, Cellular Origin, and BeyondSemantic proximity Read ↗

Genomic Characteristics of Triple-Negative Breast Cancer Nominate Molecular Subtypes That Predict Chemotherapy ResponseSemantic proximity Read ↗

Breast cancer stem cells: are we ready to go from bench to bedside?Semantic proximity Read ↗

Biological and Molecular Heterogeneity of Breast Cancers Correlates with Their Cancer Stem Cell ContentSemantic proximity Read ↗

An update on cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancerSemantic proximity Read ↗

Cancer Stem Cell Transcriptome Landscape Reveals Biomarkers Driving Breast Cancer HeterogeneitySemantic proximity Read ↗

Deciphering Common Traits of Breast and Ovarian Cancer Stem Cells and Possible Therapeutic ApproachesSemantic proximity Read ↗

Advances in the Understanding of the Pathogenesis of Triple-Negative Breast Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.